News for 'Suven'

PE fund Advent to buy Suven Pharma

Global private equity investor Advent International on Monday said it is acquiring a significant stake in Suven Pharmaceuticals from its promoters, the Jasti family. The PE major said this will be followed with an open offer to acquire 26 per cent more in the listed contract development and manufacturing organisation from public shareholders, and also merge the company with investee company Cohance Lifesciences, as per an official statement. Media reports on a Monday morning pegged the acquisition at Rs 6,300 crore, and that Advent had pipped rival Blackstone for the acquisition.

Suven ties up with Eli Lilly

Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research for central nervous system disorder.

Suven Pharmaceuticals buys US-based firm

Suven Pharmaceuticals' wholly owned subsidiary, Suven Life Sciences USA, has acquired the assets of the US-based Synthon Chiragenics, according to a release issued by Suven Pharmaceuticals to the BSE on Tuesday.

Suven sets up US development centre

Suven Life in research talks with US firms

Pharma research outsourcing faces speed bumps

Major drug discovery outsourcing deals have almost dried up in the past 18 months for almost all prominent players in the area

Korean drug majors eye local pacts

4 life science firms tie up to project R&D might

Holding too many stocks in your portfolio?

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Should you accumulate this stock for 15-20 years?

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

ASK AJIT: Are these stocks good to hold for one year?

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

'Is investing in gold, govt bonds better than stocks?'

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Expert advice: Avoid these stocks and IPOs

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex rises 145 points to end at fresh 2016 high

n the broader market, both the BSE Midcap and Smallcap indices, were up 1.2% and 0.7% each.

10 stocks that can give you high returns

Consolidation is the prime mood of the Indian equity market at the moment.

Sensex falls 251 points; oil and gas shares tumble

The Sensex ended down 251 points at 27,351 and the Nifty shed 65 points to close at 8,228.

Sensex rallies 300 points on Greece debt bailout deal

Capital Goods shares ended mixed on the back of weak IIP numbers. L&T ended down 0.7% while BHEL ended with marginal gains.

Markets end lower; Sensex holds 27,000

The 30-share Sensex ended down by 59 points at 27,027 and the 50-share Nifty slipped 7 points at 8,087.

Stocks you must buy, hold or exit

Ajit Mishra, vice president, Research, Religare Broking, answers your queries:

Winning spree intact; Sensex, Nifty soar 5% in 3 sessions

Nifty50 surged 87 points to end at 8,157, highest closing levels since Oct 29, 2015.

Sensex ends above 27,200 led by ITC

Tata Motors, ONGC, HDFC and TCS were the top gainers.

Markets end flat amid volatile trade

Custodian banks are selling dollars for their foreign fund clients.

Markets end flat amid rangebound trade; Midcaps outperform

BSE Midcap index outperformed the benchmark indices to end with 0.4% gains.

Markets end higher; Sep inflation, RIL Q2 eyed

Markets recovered in late trades, amid firm European cues, led by rebound in financials and gains in IT shares.

Sensex ends in the red amid volatile trade; IT, auto, realty fall

The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.